⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27812950 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL27781960 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL8726033 | 0.84 | — | — | |
| SCHEMBL8743122 | 0.84 | — | — | |
| Fluoride SCHEMBL28215587 | 0.84 | — | — | |
| SCHEMBL27568570 | 0.77 | — | — | |
| SCHEMBL27868842 | 0.75 | — | — | |
| Catechol SCHEMBL27519251 | 0.71 | ALDH1A1 (0.43) | — | |
| Toluene SCHEMBL20644134 | 0.69 | TSHR (0.42) | — | |
| SCHEMBL524863 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12582710-B2 | Single-chain coronavirus viral membrane protein complexes | UNIVERSITY OF HOUSTON SYSTEM (US) | 2026-03-24 | — | — | US | disclosed |
| US-20250099570-A1 | ANTIBODIES TARGETING MARBURGVIRUS GLYCOPROTEINS AND USES THEREOF | UNIVERSITY OF MARYLAND, COLLEGE PARK | 2025-03-27 | — | — | US | disclosed |
| CN-110382519-B | Novel recombinant protein antigen of Orientia tsutsugamushi and vaccine composition using the same | 首尔大学校产业协力团 | 2024-03-12 | — | — | CN | disclosed |
| US-20230338511-A1 | SINGLE-CHAIN CORONAVIRUS VIRAL MEMBRANE PROTEIN COMPLEXES | UNIVERSITY OF HOUSTON SYSTEM | 2023-10-26 | — | — | US | disclosed |
| EP-4119947-A1 | GPC3-TARGETING DRUG WHICH IS ADMINISTERED TO PATIENT RESPONSIVE TO GPC3-TARGETING DRUG THERAPY | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-01-18 | — | — | EP | disclosed |
| US-20220389511-A1 | SYSTEMS AND METHODS FOR ARTIFICAL INTELLIGENCE BASED CELL ANALYSIS | AIKILI BIOSYSTEMS INC (US) | 2022-12-08 | — | — | US | disclosed |
| WO-2022169267-A1 | METHOD AND KIT FOR DETECTING LUNG CANCER BLOOD BIOMARKER | 제노마인(주) | 2022-08-11 | — | — | WO | disclosed |
| EP-4028942-A1 | SYSTEMS AND METHODS FOR ARTIFICIAL INTELLIGENCE BASED CELL ANALYSIS | Aikili Biosystems, Inc. (US) | 2022-07-20 | — | — | EP | disclosed |
| EP-3557260-B1 | GPC3-TARGETING DRUG WHICH IS ADMINISTERED TO PATIENT RESPONSIVE TO GPC3-TARGETING DRUG THERAPY | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2022-05-18 | — | — | EP | disclosed |
| WO-2022047176-A2 | SINGLE-CHAIN CORONAVIRUS VIRAL MEMBRANE PROTEIN COMPLEXES | UNIVERSITY OF HOUSTON SYSTEM (US) | 2022-03-03 | — | — | WO | disclosed |
| US-20070059784-A1 | Methods for measuring the insulin receptor alpha subunit | MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD. (JP) | 2007-03-15 | — | — | US | disclosed |
| EP-1648506-A1 | METHOD FOR TREATING SYNOVIAL SARCOMA | Oncotherapy Science, Inc. (JP) | 2006-04-26 | — | — | EP | disclosed |
| EP-1624305-A1 | METHOD OF MEASURING INSULIN RECEPTOR alpha SUBUNIT | Ebina, Yosuke (JP) | 2006-02-08 | — | — | EP | disclosed |
| EP-1605266-A1 | UROTHELIAL CANCER TUMOR MARKER | TSS Biotech Inc. (JP) | 2005-12-14 | — | — | EP | disclosed |
| US-20050272063-A1 | Identifying an agent that inhibits the expression of frizzled 10 protein by contacting a test sample, such as a tumor cell, with a test agent and determining expression level with an antibody; screening for a compound that binds to FZD; diagnosis and treatment of synovial sarcoma | ONCOTHERAPY SCIENCE, INC. | 2005-12-08 | — | — | US | disclosed |
| WO-2005004912-A1 | METHOD FOR TREATING SYNOVIAL SARCOMA | ONCOTHERAPY SCIENCE, INC. (JP) | 2005-01-20 | — | — | WO | disclosed |
| US-20040248217-A1 | Tumor marker for urothelial carcinoma | TSS BIOTECH INC. (JP) | 2004-12-09 | — | — | US | disclosed |
| WO-2004020668-A2 | METHOD FOR TREATING SYNOVIAL SARCOMA | ONCOTHERAPY SCIENCE, INC. (JP) | 2004-03-11 | — | — | WO | disclosed |
| US-5733549-A | LOW HOMOLOGY WITH LOW DENSITY LIPOPROTEINS; ARTERIOSCLEROSIS TREATMENT | SHINO-TEST CORPORATION (JP) | 1998-03-31 | — | — | US | disclosed |
| EP-0621284-A1 | PEPTIDES CONTAINING RESPECTIVE AMINO ACID SEQUENCES SELECTED FROM AMONG THOSE OF LIPOPROTEIN(a) AND APOLIPOPROTEIN(a), ANTIBODIES RESPECTIVELY RECOGNIZING THESE AMINO ACID SEQUENCES, AND METHOD OF ASSAYING WITH THESE ANTIBODIES | SHINO-TEST CORPORATION (JP) | 1994-10-26 | — | — | EP | disclosed |